Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Japan
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
- Where
- Minato-ku
- Age
- 18 years and over
- People
- 36
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07541833 - No phaseTaking peopleMavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
- Where
- Tokyo
- Age
- 18 years and over
- People
- 200
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07383025